Susan Bal
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 57
- Multiple Myeloma Research and Treatments 56
- Oncology 37
- CAR-T cell therapy research 14
- Peptidase Inhibition and Analysis 12
- Cancer Treatment and Pharmacology 7
- Co-authors
- Luciano J. Costa (56 shared papers)Smith Giri (39 shared papers)Kelly Godby (38 shared papers)Natalie S. Callander (20 shared papers)Anita D’Souza (11 shared papers)Robert F. Cornell (10 shared papers)Saurabh Chhabra (14 shared papers)Timothy M. Schmidt (11 shared papers)
- Journals
- Blood (31 papers)British Journal of Haematology (6 papers)Journal of Clinical Oncology (4 papers)Transplantation and Cellular Therapy (3 papers)Biology of Blood and Marrow Transplantation (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Susan Bal
70 papers receiving 733 citations
Susan Bal's Hit Papers
Peers
Comparison fields: 5 of 53
- Hematology 514
- Oncology 362
- Genetics 67
- Molecular Biology 362
- Immunology 63
Countries citing papers authored by Susan Bal
This map shows the geographic impact of Susan Bal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Bal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Bal more than expected).
Fields of papers citing papers by Susan Bal
This network shows the impact of papers produced by Susan Bal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Bal. The network helps show where Susan Bal may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Bal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 151 | |
| 2 | Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2023 | 82 |
| 3 | 2020 | 69 | |
| 4 | 2023 | 41 | |
| 5 | 2023 | 34 | |
| 6 | 2022 | 32 | |
| 7 | 2019 | 30 | |
| 8 | Multiple myeloma with t(11;14): unique biology and evolving landscape. | 2022 | 28 |
| 9 | 2014 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2021 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2010 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2020 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2019 | 8 | |
| 20 | 2020 | 8 |
About Susan Bal
Susan Bal is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Infectious Diseases, having authored 82 papers that have together received 741 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (56 papers), Protein Degradation and Inhibitors (22 papers), CAR-T cell therapy research (14 papers), Peptidase Inhibition and Analysis (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Cancer Treatment and Pharmacology (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Hematology (514 citations), Oncology (362 citations), Genetics (67 citations), Molecular Biology (362 citations) and Immunology (63 citations). Susan Bal has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Luciano J. Costa, Smith Giri, Kelly Godby, Natalie S. Callander, Anita D’Souza, Robert F. Cornell, Saurabh Chhabra, Timothy M. Schmidt, Eva Medvedova and Bhagirathbhai Dholaria. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Transplantation and Cellular Therapy and Biology of Blood and Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.